Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are over 18 years old
- You have been diagnosed with a deep vein thrombosis (DVT – a blood clot in a deep vein) that either happened on its own, was caused by a specific event (such as surgery), or is related to cancer
- Your blood clot is located in a vein in one or both of your legs (either in the upper or lower part of the leg), and you had an ultrasound scan to confirm this within 6 months of being diagnosed
- You are able to understand the trial and give your consent to take part
Who may not be able to join:
- Your blood clot is only in your arm or in another location in your body, and you do not also have a clot in your leg
- You have a clot in a vein close to the skin surface (called a superficial clot), and you do not also have a deeper clot in your leg
- Your blood clot is connected to or caused by a central venous catheter (a tube placed into a large vein, often for medical treatment)
- You have been diagnosed with certain types of skin cancer (epithelial or basal cell carcinoma), as these are considered low-risk for the type of blood clot this trial is studying
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Benilde Cosmi, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phone: 051 2142483
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Frequency of POA (Peripheral Obliterative Arteriopathy); Assess the presence of atherosclerotic plaques and the IMT (Intima-Media Thickness)of the common carotid artery; Evaluate the correlation between ABI, IMT measurements, and DVT
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.